Humacyte

Humacyte is a clinical-stage biotechnology platform company that develops universally implantable, bioengineered human tissues and advanced tissue constructs. Its lead product is the Human Acellular Vessel (HAV), marketed as Symvess, an acellular tissue engineered vessel for vascular trauma. Its mission is to transform medicine by delivering off-the-shelf bioengineered tissues that can address vascular injury, dialysis access and other diseases.